Centrum Badawczo – Rozwojowe Novasome sp. z o.o. and Pikralida sp. z o.o.

are collaborating on the research project titled Development of an innovative pilot line and its validation under real conditions using synthesis process of a model active pharmaceutical ingredient.

The project POIR.01.01.01-00-0072/21 is co-financed by the European Funds.

The aim of the Project is to develop a technology innovation and to verify the latter in real conditions using a pilot kilo-lab line that enables efficient and safe synthesis of active pharmaceutical ingredients (APIs). The Project will involve the design of a process system to allow for a variety of synthesis processes as well as the on-line monitoring of how individual reactions proceed. Once implemented, the innovation will contribute to the integrity of supply chains and availability of APIs, and therefore to ensuring pharmaceutical sovereignty in the EU.

Total Project Budget: 9 582 401,43 PLN

Funding from European Funds: 5 765 803,30 PLN

Project Period: 01.07.2021 – 31.12.2023

The project is co-financed by the European Union under the Smart Growth Operational Program 2014-2020. The program is implemented as part of the call organized by the National Centre for Research and Development 1/1.1.1/2021 Fast Track.

Extension of NOVASOME Research and Development Centre Sp. z o.o. to develop innovative projects


Measure 1.2 Innovative enterprises

Sub-measure: 1.2.1 Innovative enterprises – horizontal competition

Scheme: 1.2 B Creation and development of R&D enterprises infrastructure

Total value of the project PLN 9 208 492,13

Co-financing amount PLN 1,499,005.33

Project duration: October 2016 – December 2017

The aim of the project is the development of Novasome R&DC by investing in analytical and technological equipment, intangible assets and other necessary infrastructure that will be used to conduct scientific research and development works for the creation of innovative products and services in the areas indicated in the R&D work plan.

The project includes:

  • acquisition of analytical and technological equipment for the R&D Department;
  • acquisition of computer hardware;
  • installation works associated with the connection of R&D devices, and modernisation works related to the adaptation of the ground floor for the disabled;
  • participation of R&D staff in training to improve their skills, including in the use of new research equipment;
  • informational and promotional activities for the project.


Transformation of Novasome R&DC Sp. z o.o. into a Research and Development Centre


Priority axis 4. Investments in innovation

Measure: 4.2. Stimulating R&D activities and support in the field of industrial design

The total value of the project is PLN 5,813,074.30

Co-financing amount PLN 1,905,926.00

Project implementation period August 2008 – September 2009

The implementation of the project contributed to the applicant obtaining the status of a Research and Development Centre in accordance with the Act on certain forms of supporting innovative activity.

The aim of the project was to create new laboratories and modernise existing ones, which helped broaden the company’s offer and increase revenues from research activities.

The aim of the project was achieved by creating four new laboratories:

  1. Laboratory of high-risk substances;
  2. Laboratory of numerical analysis;
  3. Tablet technology laboratory;
  4. Calorimetric laboratory;

and modernisation of five existing laboratories:

  1. Laboratory of lipid and amphiphilic substance analysis;
  2. Laboratory of particle size and shape analysis;
  3. Ointment technology laboratory;
  4. Laboratory of liposomal technologies;
  5. Stability test laboratory.

The results of the research work have found applications in the pharmaceutical, food and cosmetics industries.